STAT

DECEMBER 20, 2023

But after two years of steady decline, 2024 might finally prove them right. Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

341

341

STAT

OCTOBER 30, 2024

The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics. 

292

292

STAT

FEBRUARY 28, 2024

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers.

358

358

STAT

DECEMBER 26, 2023

On the policy side, the industry grappled with changing AI regulations, reimbursement woes, and device sterilization rules.

316

316

STAT

JANUARY 18, 2024

And what’s going to move markets in 2024? We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Why are rich biotechs cutting costs? Has JPM Week already worn off? Read the rest…

278

278

STAT

DECEMBER 13, 2023

Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares to tumble 7% in early trading. Pfizer said that its full-year revenue for 2024 should fall between $58.5 The reduced earnings numbers cap a difficult year for the drug giant. billion and $61.5

Vaccines 316

Vaccines 316

STAT

OCTOBER 24, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read  Read an excerpt from each below.

Pharmaceutical Companies 265

Pharmaceutical Companies Pharmaceutical Companies 265

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363

363

STAT

OCTOBER 7, 2024

“I’ve won 10 to 20 awards in the last 20 years, but never had a press conference with cameras and nothing like this,” Ruvkun, who along with Victor Ambros received the 2024 award in medicine or physiology on Monday, said at a press conference at Massachusetts General Hospital.

Medical Schools 341

Medical Schools Diabetes Hospitals 341

STAT

DECEMBER 28, 2023

STAT’s taking a look at some of the recent health policy trends that states will start to implement in 2024. For most states, the new year means a new legislative session.

Drug Pricing 294

Drug Pricing Hospitals 294

STAT

DECEMBER 27, 2023

WASHINGTON — The Food and Drug Administration has a lot on its plate in 2024 with the reorganizations of its food center and the office that inspects FDA-regulated facilities. Amid that massive reorganization, the FDA also will lose one of its most influential leaders.

274

274

STAT

JANUARY 7, 2024

Greetings from JPM Week 2024! Want to stay on top of the science and politics driving biotech today?    Sign up to get our biotech newsletter in your inbox.

284

284

STAT

MAY 20, 2024

STAT took a look at 20 large nonprofit health systems and found that all but four reported higher operating and net margins in the first three months of 2024 compared with the same period in 2023. Hospitals are seeing more patients and cutting down on the expensive contract labor they relied on during the Covid-19 pandemic.

Hospitals 302

Hospitals 302

STAT

AUGUST 8, 2024

The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. billion to $46.6 billion from the previously guided range of $42.4 from the previously guided $13.50

Diabetes 312

Diabetes 312

STAT

FEBRUARY 1, 2023

cut to baseline payments in 2024, the Biden administration said Wednesday. Medicare Advantage insurers could face an average 2.3% If the proposal stands, it would be a net cut of more than $3 billion to the industry.

308

308

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.    With all eyes currently on the upcoming U.S.

Pharmaceutical Companies 262

Pharmaceutical Companies Pharmaceutical Companies Drug Development 262

STAT

FEBRUARY 29, 2024

Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ! Previous Winners   |  Official Rules   |  FAQ

72

72

STAT

JANUARY 19, 2024

That suggests to me that 2024 will be a better year for the industry’s job seekers. My time was packed with the usual mix of requests from potential, current, and former clients as well as investors to discuss search projects, and of course the meeting requests from potential candidates. ” requests as last year.

289

289

STAT

JANUARY 4, 2024

Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

347

347

STAT

JANUARY 3, 2024

Hospitals and clinics are expecting a slightly better 2024 compared to last year thanks to a return to mostly in-person care, patients resuming preventive visits and the gradual easing of labor costs and shortages.

Hospitals 313

Hospitals 313

STAT

DECEMBER 22, 2023

As we enter the fifth year of this challenging decade, life finally appears to be inching toward normal — a new normal — on the infectious diseases front. Humans and the SARS-CoV-2 virus seem to be making progress toward a detente with each other. Covid is still a major disruptor, a significant cause of illness and death.

357

357

STAT

JANUARY 12, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

287

287

STAT

JANUARY 9, 2024

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

344

344

PharmaVoice

DECEMBER 18, 2023

Advancements in cloud and AI technology will transform clinical trial efficiency and engagement.

340

340

STAT

JULY 13, 2023

for 2024, the federal government said Thursday. Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue. The base figure that determines how much physicians get paid by Medicare will decrease by 3.3%

Hospitals 245

Hospitals 245

PharmaVoice

DECEMBER 20, 2024

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

147

147

STAT

OCTOBER 9, 2024

LONDON — A trio of scientists who opened new doors in our understanding of the structure of proteins — the fundamental building blocks of biology — and even came up with ways to create new proteins won the Nobel Prize in chemistry Wednesday.

348

348

STAT

JANUARY 4, 2024

Health tech hopefuls might once have been used to a wealth of job options, especially in the pandemic’s early stages when investors pumped record-breaking dollar amounts into an unprecedented number of ventures.

310

310

STAT

OCTOBER 22, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.    Sign up to get it  delivered in your inbox every Tuesday and Thursday. Will ‘responsible AI’ spawn a new market for tech?

317

317

STAT

OCTOBER 10, 2023

In 2024, 43% of the employers polled said they could cover GLP-1 drugs in 2024 compared to 25% that cover them now. The number of U.S.

257

257

STAT

MAY 7, 2024

Dear Readers, We are enormously proud that STAT reporters Casey Ross and Bob Herman have been named finalists for the Pulitzer Prize in the investigative reporting category “for exposing how UnitedHealth Group, the nation’s largest health insurer, used an unregulated algorithm to override clinicians’ judgments and deny care, highlighting (..)

308

308

STAT

DECEMBER 27, 2023

As another year comes to an end and the world seems to hit the proverbial pause button, the temptation to look ahead is too great to ignore. After all, this is what journalists like to do as the calendar turns another page. So once again, we will take a whack at identifying some of the most noteworthy developments to watch.

Drug Pricing 279

Drug Pricing 279

STAT

MAY 28, 2024

The ASCO annual meeting is widely considered one of the largest and most prestigious cancer research conferences in the world. From May 31-June 4, more than 40,000 oncology professionals will gather in Chicago for an event featuring 200 professional sessions and the presentation of more than 5,000 abstracts.

254

254

STAT

AUGUST 12, 2024

A few recent examples make the point: A New York Times story in June 2024 bore the headline, “Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government.”

Drug Pricing 339

Drug Pricing 339

STAT

DECEMBER 29, 2023

drug crisis is as bad as it’s ever been, and there are few signs things are getting better. About 110,000 people died of drug overdoses in 2023, about the same as in previous years. Fentanyl, the powerful synthetic opioid that now dominates the illicit drug market, remained the main culprit.

324

324

STAT

NOVEMBER 18, 2024

CHICAGO — This year’s scientific sessions on the latest research in cardiovascular disease began not with the buzzy new obesity drugs but with a sobering look at progress stalling or even reversing in common chronic illnesses.

Hospitals 314

Hospitals 314